Mutual of America Capital Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-41,491
Closed -$7.17M 1290
2015
Q1
$7.17M Buy
41,491
+1,318
+3% +$193K 0.16% 122
2014
Q4
$4.62M Buy
40,173
+54
+0.1% +$6.54K 0.1% 251
2014
Q3
$6.27M Buy
40,119
+558
+1% +$80.9K 0.15% 126
2014
Q2
$4.88M Sell
39,561
-12,851
-25% -$1.42M 0.11% 203
2014
Q1
$5.43M Sell
52,412
-7,659
-13% -$784K 0.13% 168
2013
Q4
$5.4M Sell
60,071
-16,741
-22% -$1.34M 0.13% 166
2013
Q3
$5.14M Buy
76,812
+31,008
+68% +$2.14M 0.14% 156
2013
Q2
$3.03M Buy
+45,804
New +$2.62M 0.09% 322

Other funds holding SLXP

Mutual of America Capital Management's SLXP Position: Q2 2015 in Review

Mutual of America Capital Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 41,491 shares — an estimated $7.17M sold.

Mutual of America Capital Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $7.17M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Mutual of America Capital Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Mutual of America Capital Management sold 41,491 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $7.17M.
  • Mutual of America Capital Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Mutual of America Capital Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $7.17M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Mutual of America Capital Management's 13F filing for Q2 2015, filed 5 Aug 2015.